Cite
HARVARD Citation
Heijl, C. et al. (2011). Incidence of malignancy in patients treated for antineutrophil cytoplasm antibody-associated vasculitis: follow-up data from European Vasculitis Study Group clinical trials. Annals of the rheumatic diseases. 70 (8), pp. 1415-1421. [Online].